Literature DB >> 20165662

Exercise testing in assessment and management of patients in clinical practice - present situation.

Sumer S Choudhary1, Sanjiw Choudhary.   

Abstract

Entities:  

Keywords:  6min walk test; Exercise; Interpretation; heart; methodology; testing

Year:  2008        PMID: 20165662      PMCID: PMC2822334          DOI: 10.4103/0970-2113.59592

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


× No keyword cloud information.
To review recent scientific advances in exercise testing methods and results that is important for a clinical practioner. To understand the utility and limitations of different methods of exercise testing. To understand appropriate method in assessment and management of patients. To appreciate that exercise testing results can have greater clinical meaning when interpreted in context of relevant patient information. To understand that additional study is required to further characterize both current and future roles of exercise testing in clinical medicine.

INTRODUCTION

The need of the hour is to understand the different methods used worldwide to asses the patients exercise performance and response in clinical practice. Clinical Exercise Testing (CET) is increasingly gaining importance in clinical medicine, by helping the clinician to objectively evaluate the physiological functions. The result helps to predict the outcome and mortality in different clinical circumstances.

COMMON METHODS TO ASSES EXERCISE RESPONSE AND PERFORMANCES IN CLINICAL PRACTICE

Simple test are easily performed but limits physiological understanding. More comprehensively performed tests may provide detail information and understanding but is costly and demanding. The clinician has to choose the type of test to perform for a particular patient Commonly the following test is performed worldwide:- 6 min walk test Shuttle Walk Test Exercise Induced Bronchoconstriction Test Cardiac Stress Test Clinical Exercise Test (CET)

6 MINUTE WALK TEST

It is a safe simple and practical test of sub maximal functional capacity, which measures the maximum distance walked by a subject in 6 minutes. Advantage of this test is that it provides an acceptable index of functional disability and correlates with oxygen uptake measured during comprehensive testing. This test gives very limited information regarding physiological contributors to activity related symptoms or about mechanism of exercise limitation. Currently this test is used in lung transplantation, lung volume reduction surgery, pulmonary rehabilitation and in predicting mortality in cardiac patients and patients with pulmonary vascular disorders.

SHUTTLE WALK TEST

It measures the distance walked by a patient in a 10 meter course, being paced by an audio signals from a cassette. The intensity of exercise reached is comparable to test performed on a treadmill, as the walking speed is progressively increased until the patient reaches exhaustion. Modification of maximal SWT for determination of endurance performance – similar to maximal and constant (sub maximal) cycle ergometry may be done.

EXERCISE INDUCED BRONCHOCONSTRICTION

In this physical activity triggers acute airway narrowing in patients with heightened airway responsiveness. In susceptible patients EIB typically occurs 5 to 10 minutes after exercise. and generally resolves in 20 to 30 minutes. In some clinical situation where bronchial challenge is unavailable or not diagnostic EIB should be undertaken. Common protocols to be followed include exercise on treadmill or cycle ergometry at a workload of 60 %to 80% of predicted maximum or the intensity that will elicit a heart rate of 80% of predicted maximum for 6 to 8 minutes. The goal is to produce ventilation equal to those attained during activity to produce symptom of EIB. 15% percent decrease in FEV1 following exercise is diagnostic of EIB. And 10-15 % decrease in FEV1 would be suggestive of EIB.

CARDIAC STRESS TEST

Common type of exercise testing, the primary purpose of which is diagnosis and management of myocardial infarction. Bruce protocol is commonly used and the single most reliable indication of ischemia is ST segment depression. During this test ECG and BP is measured, but the utility may be enhanced by concurrent measurement of ventilator parameters and respiratory gas exchange.

CLINICAL EXERCISE TESTING (CET)

CET involves the measurement of respiratory gas exchange i.e. oxygen uptake, carbon dioxide, minute ventilation, other variables while monitoring ECG, blood pressure, pulse oximetry and exertion perceived (Borg Scale) during a maximal symptom limited incremental test on a cycle ergo meter or treadmill. Simultaneous measurement of blood gasses and spirometry provides with more detail information on gas exchange and ventilation. CET provides a global assessment of integrative exercise responses which are not adequately reflected by measurement of individual organ system function on rest. Peak oxygen uptake remains the gold standard for exercise capacity. It has tradionaly been undertaken with an incremental stepwise or ramp control protocol to exhaustion. In patients of COPD, acute response to an inhaled bronchodilator was assessed using various exercise tests. The authors found endurance time with a constant – workload exercise (80% of maximal work rate)was the most responsive end point to the effect of bronchodilator showing 19% improvement in exercise duration time. Arterial blood gasses measured at 5 minute constant – work exercise testing may give practical and cost effective alternative when arterial oxygen saturation, PaO2, alveolar –arterial oxygen pressure difference and ratio of physiological dead space to tidal volume are required. Evaluation of Exercise Intolerence Evaluation of Unexplained exertional Dysponea Evaluation of patients of cardiovascular diseases Evaluation of Patients of respiratory diseases - COPD - ILD - Pulmonary Vascular Diseases - Cystic Fibrosis Preoperative evaluation Evaluation for transplantation and Lung Volume Reduction Surgeries Pulmonary Rehabilitation Impairment disability

INDICATIONS FOR EXERCISE TESTING IN CLINICAL PRACTICE

Table 1 to 11 illustrates the indication, contraindication and guidelines laid down by various international authorities for cardio pulmonary exercise testing in clinical setting.
Table I

Overview of Cardiopulmonary Exercise Testing

Clinical Status Evaluation
Clinical diagnosis and reason(s) for CPET
Health questionnaire (cardiopulmonary); physical activity profile
Medical and occupational history and physical examination
PFTs, CXR, ECG, and other appropriate laboratory tests.
Determination of indications and contraindications for CPET
Pretest Procedures
Abstain from smoking for at least 8 h before the test
Refrain from exercise on the day of the test
Medications as instructed
Consent form
Conduct of CPET
Laboratory procedures
   Quality control
   Equipment calibration
Protocol Selection
   Incremental versus constant work rate; invasive versus
   nominvasive
Patient preparation
   Familiarization
   12-lead ECG, pulse oximetry, blood pressure
   Arterial line (if warranted)
Cardiopulmonary exercise testing
Interpretation of CPET Results
Data processing
Quality and consistency of results
Comparison of results with approprate reference values
Integrative approach to interpretation CPET results
Preparation of CPET report

Definition of abbreviations : CPET = Cardiopulmonary exercise testing; CXR = chest X-ray; ECG; electrocardiogram; PFTs = pulmonary function tests.

Table XI

Selected reference values for maximal incremental cycle exercise test

VariablesEquations*
Vo2, ml/min, maleW X [50.75 − 0.372 (A)]
Vo2, ml/min, female(W − 43) × [22.78 − 0.17 (A)]
HR, beats/min210 × 0.65 (A)*
O2 pulse, ml/beatPredicated Vo2 max/predicted HRmax
Ve/MVV, %˜ 72 + 15
AT, L/min (Vo2)> 40% Vo2 pred

Definition of abbreviations : AT = Anaerobic threshold; HR = heart rate; Ve = minute ventilation; Vo2 = oxygen uptake.

Data from Referenes 32, 33 and 34

Age (A) : years; height (H) : centimeters; weight (W), kilograms.

Predicted weight men : 0.79 × H − 60.7. Predicted weight women: 0.65 × H − 42.8. When actual weight > predicted, the predicted weight should be used in the equations. Wasserman and colleagues introduced new corrections factors (34, 28), which have not yet been published in peer reviewed journals.

^ See Lange-Andersen and coworkers (345).

CONCLUSION

Cardiopulmonary exercise test is a helpful tool for evaluation of the disease and management in clinical practice and rapidly evolving in one of the important investigative and diagnostic test. There are different methods used in various clinical setting. The clinical exercise testing a simple and easy to perform test for a pulmonologist as compared to the other conducted tests and relatively more simpler and cost effective test, which needs to be more frequently used in our day to day clinical practice in relevant patients. Overview of Cardiopulmonary Exercise Testing Definition of abbreviations : CPET = Cardiopulmonary exercise testing; CXR = chest X-ray; ECG; electrocardiogram; PFTs = pulmonary function tests. Indications for Cardiopulmonary Exercise Testing Determination of functional impairment or capacity (peak Vo2) Determination of exercise-limiting factors and pathophysiologic mechanisms. Assessing contribution of cardiac and pulmonary etiology in coexisting disease. Symptoms disproportionate to resting pulmonary and cardiac tests. Unexplained dyspnea when initial cardiopulmonary testing is nondiagnostic. Functional evaluation and prognosis in patients with heart failure Selection for cardiac transplantation Exercise prescription and monitoring response to exercise training for cardiac rehabilitation. (special circumstance; i.e. pacemakers) Functional impairement asessment (see specific clinical applications) Chronic obstructive pulmonary disease Establishing exercise limitation(s) and assessing other potential contributing factors, especially occult heart disease (ischemia) Determination of magnitude of hypoxemia and for O2 prescription When objective determination of therapeutic intervention is necessary and not adequately addressed by standard pulmonary function testing. Interstitial lung diseases Detection of early (occult) gas exchange abnormalities Overall assessment/ monitoring of pulmonary gas exchange Determination of magnitude of hypoxemia and for O2 prescription Determination of potential exercise-limiting factors Documentation of therapeutic response to potentially toxic therapy Pulmonary vascular disease (careful risk-benefit analysis required) Cystic fibrosis Exercise-induced bronchospasm Preoperative evaluation Lung resectional surgery Elderly patients undergoing major abdominal surgery Lung volume resectional surgery for emphysema (currently investigational) Exercise evaluation and prescription for pulmonary rehabilitation Evaluation for impairment-disability Evaluation for lung, heart-lung transplantation Definition of abbreviations : Vo2 = oxygen consumption Reference 20 Absolute and Relative Contraindications for Cardiopulmonary Exercise Test References 21, 22 and 23. Exercise patient with supplemental O2. Indications for Exercise Termination Definition of abbreviations : ECG = electrocardiogram; Spo2 = arterial oxygen saturation as indicated by pulse oximetry. References 22, 24, 25 and 26. Usual Cardiopulmonary Exercise Response Patterns Definition of abbreviations : AT = anaerobic threshold; COPD = chronic obstructrutive pulmonary disease; HR = heart rate; ILD = interstitial disease; MVV = maximal voluntary ventilation; P(A-a)O2 = alveolar-arterial difference for oxygen pressure; VD/VT = ratio of physiologic dead space to tidal volume; VE = minute ventilation; Vco2 = carbon dioxide output; Vo2 max = maximal oxygen uptake; Vo2 peak = peak oxygen uptake. References 37, 38 and 28 Decreased, normal, and increased are with respect to the normal response. Measurements during Cardiopulmonary Exercise Testing Definition of abbreviations : ABGs = Arterial blood gases; AT = anaerobic threshold; BP = Blood pressure; ECG = electrocardiogram; fR = respiratory frequency; HR = heart rate; P(A-a)O2 = alveolar-arterial difference for oxygen pressure; Paco2 = arterial carbon dioxide pressure; Pao2 = arterial oxygen pressure; PET-co2 = end-tidal Pco2; PETo2, = end-tidal Po2; RER = respiratory exchange ratio; Sao2 = arterial oxygen saturation; Spo2 = arterial oxygen saturation as indicated by pulse oximetry; Vco2 = carbon dioxide output; VE = minute ventilation; VD/VT = ratio of physiologic dead space to tidal volume; Vo2 = oxygen uptake; VT = tidal volume; WR = work rate. 31 Suggested normal guidelines for interpretation of Cardiopulmonary Exercise Testing References 27, 28, 30, 35, 22 and 32 * Maximum or peak cardiopulmonary responses except for anaerobic threshold and VE/Vco2 at AT. Integrative approach to the interpretation of Cardiopulmonary exercise testing results Definition of abbreviations : CPET = cardiopulmonary exercise testing; HR = heart rate; Sao2 = arterial oxygen saturation; Ve = minute ventilation; Vo2 = oxygen uptake. Reference 27 Cardiopulmonary Exercise Response Patterns Definition of abbreviations : AT = anaerobic threshold; COPD = chronic obstructrutive pulmonary disease; HR = heart rate; ILD = interstitial disease; MVV = maximal voluntary ventilation; P(A-a)O2 = alveolar-arterial difference for oxygen pressure; VD/VT = ratio of physiologic dead space to tidal volume; VE = minute ventilation; Vco2 = carbon dioxide output; Vo2 max = maximal oxygen uptake; Vo2 peak = peak oxygen uptake. References 37, 36, 28 * Decreased, normal, and increased are with respect to the normal response. Selected reference values for maximal incremental cycle exercise test Definition of abbreviations : AT = Anaerobic threshold; HR = heart rate; Ve = minute ventilation; Vo2 = oxygen uptake. Data from Referenes 32, 33 and 34 Age (A) : years; height (H) : centimeters; weight (W), kilograms. Predicted weight men : 0.79 × H − 60.7. Predicted weight women: 0.65 × H − 42.8. When actual weight > predicted, the predicted weight should be used in the equations. Wasserman and colleagues introduced new corrections factors (34, 28), which have not yet been published in peer reviewed journals. ^ See Lange-Andersen and coworkers (345).
Table II

Indications for Cardiopulmonary Exercise Testing

Evaluation of exercise tolerance

Determination of functional impairment or capacity (peak Vo2)

Determination of exercise-limiting factors and pathophysiologic mechanisms.

Evaluation of undiagnosed exercise intolerance

Assessing contribution of cardiac and pulmonary etiology in coexisting disease.

Symptoms disproportionate to resting pulmonary and cardiac tests.

Unexplained dyspnea when initial cardiopulmonary testing is nondiagnostic.

Evaluation of patients with cardiosvascular disease

Functional evaluation and prognosis in patients with heart failure

Selection for cardiac transplantation

Exercise prescription and monitoring response to exercise training for cardiac rehabilitation.

(special circumstance; i.e. pacemakers)

Evaluation of patients with respiratory disease

Functional impairement asessment (see specific clinical applications)

Chronic obstructive pulmonary disease

Establishing exercise limitation(s) and assessing other potential contributing factors, especially occult heart disease (ischemia)

Determination of magnitude of hypoxemia and for O2 prescription

When objective determination of therapeutic intervention is necessary and not adequately addressed by standard pulmonary function testing.

Interstitial lung diseases

Detection of early (occult) gas exchange abnormalities

Overall assessment/ monitoring of pulmonary gas exchange

Determination of magnitude of hypoxemia and for O2 prescription

Determination of potential exercise-limiting factors

Documentation of therapeutic response to potentially toxic therapy

Pulmonary vascular disease (careful risk-benefit analysis required)

Cystic fibrosis

Exercise-induced bronchospasm

Specific clinical applications

Preoperative evaluation

Lung resectional surgery

Elderly patients undergoing major abdominal surgery

Lung volume resectional surgery for emphysema (currently investigational)

Exercise evaluation and prescription for pulmonary rehabilitation

Evaluation for impairment-disability

Evaluation for lung, heart-lung transplantation

Definition of abbreviations : Vo2 = oxygen consumption Reference 20

Table III

Absolute and Relative Contraindications for Cardiopulmonary Exercise Test

AbsoluteRelative
Acute myocardial infarction (3-5 days)Left main coronary stenosis or its equivalent
Unstable anginaModerate stenotic valvular heart disease
Uncontrolled arrhythmias causing symptomsSevere untreated arterial hypertension at rest
or hemodynamic compromise(> 200 mm Hg systolic, > 120 mm Hg diastolic)
SyncopeTachyarrhythmias or bradyarrhymias
Active endocarditiesHigh-degree atrioventricular block
Acute myocarditis or pericarditisHypertrophic cardiomyopathy
Symptomatic severe aortic stenosisSignificant pulmonary hypertension
Uncontrolled heart failureAdvanced or complicated pregnancy
Acute pulmonary embolus or pulmonary infarctionElectrolyte abnormalities
Thrombosis of lower extremitiesOrthopedic impairment that compromises exercise performance
Suspected dissecting aneurysm
Uncontrolled asthma
Pulmonary edema
Room air desaturation at rest < 85%*
Respiratory failure
Acute noncardiopulmonary disorder that may affect exercise performance or be aggrevated by exercise (i.e. infection, renal failure, thyrotoxicosis)
Mental impairment leading to inability to cooperate

References 21, 22 and 23.

Exercise patient with supplemental O2.

Table IV

Indications for Exercise Termination

Chest pain suggestive of ischemia
Ischemic ECG changes
Complex ectopy
Second or third degree heart block
Fall in systolic pressure > 20 mm Hg from the highest value during the test
Hypertension (> 250 mm Hg systolic; > 120 mm Hg diastolic)
Severe desaturation : Spo2 < 80% when accompanied by symptoms and signs of severe hypoxemia
Sudden pallor
Loss of coordination
Mental confusion
Dizziness or faintness
Signs of respiratory failure

Definition of abbreviations : ECG = electrocardiogram; Spo2 = arterial oxygen saturation as indicated by pulse oximetry.

References 22, 24, 25 and 26.

Table V

Usual Cardiopulmonary Exercise Response Patterns

MeasurementHeart FailureCOPDILDPulmonary Vascular DiseaseObesityDeconditioned
Vo2max or Vo2peakDecreasedDecreasedDecreasedDecreasedDecreased for actual, normal for ideal weightDecreased
Anaerobic thresholdDecreasedNormal/decreased indeterminateNormal or decreasedDecreasedNormalNormal or decreased
Peak HRVariable, usually normal in mildDecreased, normal in mildDecreasedNormal/slightly decreasedNormal/slightly decreasedNormal/slightly decreased
O2 pulseDecreasedNormal or decreasedNormal or increasedNormalNormal or increasedNormal
(VE/MVV) × 100Normal or decreasedIncreasedIncreasedIncreasedNormalNormal
VE/Vco2 (at AT)IncreasedIncreasedIncreasedIncreasedNormalNormal
VD/VTIncreasedIncreasedIncreasedIncreasedNormalNormal
Pao2NormalVariableDecreasedDecreasedNormal/may increaseNormal
P(A-a)O2Usually normalVariably, usually increasedIncreasedIncreasedMay decreaseNormal

Definition of abbreviations : AT = anaerobic threshold; COPD = chronic obstructrutive pulmonary disease; HR = heart rate; ILD = interstitial disease; MVV = maximal voluntary ventilation; P(A-a)O2 = alveolar-arterial difference for oxygen pressure; VD/VT = ratio of physiologic dead space to tidal volume; VE = minute ventilation; Vco2 = carbon dioxide output; Vo2 max = maximal oxygen uptake; Vo2 peak = peak oxygen uptake. References 37, 38 and 28

Decreased, normal, and increased are with respect to the normal response.

Table VI

Measurements during Cardiopulmonary Exercise Testing

MeasurementsNominvasiveInvasive (Abgs)
External workWR
Metabolic gas exchangeVo2, Vco2, RER, ATLactate
CardiovascularHR, ECG, BP, O2 pulse
VentilatoryVa, Vr, fR
Pulmonary gas exchangeSpo2, Vr/Vco2, Vr/Vo2, PETO2, PETCO2Pao2, Sao2, P(A-a)O2, VD/VT
Acid-basepH, Paco2, standard HCO3
SymptomsDyspnea, fatigue, chest pain

Definition of abbreviations : ABGs = Arterial blood gases; AT = anaerobic threshold; BP = Blood pressure; ECG = electrocardiogram; fR = respiratory frequency; HR = heart rate; P(A-a)O2 = alveolar-arterial difference for oxygen pressure; Paco2 = arterial carbon dioxide pressure; Pao2 = arterial oxygen pressure; PET-co2 = end-tidal Pco2; PETo2, = end-tidal Po2; RER = respiratory exchange ratio; Sao2 = arterial oxygen saturation; Spo2 = arterial oxygen saturation as indicated by pulse oximetry; Vco2 = carbon dioxide output; VE = minute ventilation; VD/VT = ratio of physiologic dead space to tidal volume; Vo2 = oxygen uptake; VT = tidal volume; WR = work rate. 31

Table VII

Suggested normal guidelines for interpretation of Cardiopulmonary Exercise Testing

VariablesCriteria of Normality
Vo2max or Vo2 peak> 84% predicted
Anaerobic threshold> 40% Vo2max predicted; wide range of normal (40-80%)
Heart rate (HR)HRmax > 90% age predicted
Heart rate reserve (HRR)HRR < 15 beats/min
Blood pressure<220/90
O2 pulse (Vo2/HR)> 80%
Ventilatory reserve (VR)MVV - Vemax: > 11 or Vemax/MVV × 100 : < 85%.
Wide normal range : 72 + 15%
Respiratory frequency (fR)< 60 breaths/min
VE/ Vco2 (at AT)< 34
VD/VT< 0.28; < 0.30 for age > 40 years
Pao2 > 80 mm Hg
P (A-a) O2< 35 mm Hg

References 27, 28, 30, 35, 22 and 32

* Maximum or peak cardiopulmonary responses except for anaerobic threshold and VE/Vco2 at AT.

Table VIII

Integrative approach to the interpretation of Cardiopulmonary exercise testing results

1.Determine reason(s) for CPET
2.Review pertinent clinical and laboratory information (clinical status)
3.Note overall quality of test, assessment of subject effort, and reasons for exercise cessation
4.Identify key variables: initially Vo2, and then HR, VE, Sao2, and other measurements subsequently.
5.Use tabular and graphic presentation of the data
6.Pay attention to trending phenomena : submaximal through maximal responses.
7.Compare exercise responses with appropriate reference values.
8.Evaluate exercise limitation : physiologic versus nonphysiologic.
9.Establish patterns of exercise responsess.
10.Consider what conditions / clinical entities may be associated with these patterns.
11.Correlae CPET results with clinical status.
12.Generate CPET report.

Definition of abbreviations : CPET = cardiopulmonary exercise testing; HR = heart rate; Sao2 = arterial oxygen saturation; Ve = minute ventilation; Vo2 = oxygen uptake.

Reference 27

Table IX

Cardiopulmonary Exercise Response Patterns

MeasurementHeart FailureCOPDILDPulmonary Vascular DiseaseObesityDeconditioned
Vo2max or Vo2peakDecreasedDecreasedDecreasedDecreasedDecreased for actual, normal for ideal weightDecreased
Anaerobic thresholdDecreasedNormal/decreased indeterminateNormal or decreasedDecreasedNormalNormal or decreased
Peak HRVariable, usually normal in mildDecreased, normal in mildDecreasedNormal/slightly decreasedNormal/slightly decreasedNormal/slightly decreased
O2 pulseDecreasedNormal or decreasedNormal or increasedNormalNormal or increasedNormal
(VE/MVV) × 100Normal or decreasedIncreasedIncreasedIncreasedNormalNormal
VE/Vco2 (at AT)IncreasedIncreasedIncreasedIncreasedNormalNormal
VD/VTIncreasedIncreasedIncreasedIncreasedNormalNormal
Pao2NormalVariableDecreasedDecreasedNormal/may increaseNormal
P(A-a)O2Usually normalVariably, usually increasedIncreasedIncreasedmay decreaseNormal

Definition of abbreviations : AT = anaerobic threshold; COPD = chronic obstructrutive pulmonary disease; HR = heart rate; ILD = interstitial disease; MVV = maximal voluntary ventilation; P(A-a)O2 = alveolar-arterial difference for oxygen pressure; VD/VT = ratio of physiologic dead space to tidal volume; VE = minute ventilation; Vco2 = carbon dioxide output; Vo2 max = maximal oxygen uptake; Vo2 peak = peak oxygen uptake. References 37, 36, 28

* Decreased, normal, and increased are with respect to the normal response.

Table X
  24 in total

1.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Authors:  R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

Review 3.  ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing).

Authors:  R J Gibbons; G J Balady; J W Beasley; J T Bricker; W F Duvernoy; V F Froelicher; D B Mark; T H Marwick; B D McCallister; P D Thompson; W L Winters; F G Yanowitz; J L Ritchie; R J Gibbons; M D Cheitlin; K A Eagle; T J Gardner; A Garson; R P Lewis; R A O'Rourke; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1997-07       Impact factor: 24.094

Review 4.  Recommendations and standard guidelines for exercise testing. Report of the Task Force Conference on Ergometry, Titisee 1987.

Authors:  H Löllgen; H V Ulmer; P Crean
Journal:  Eur Heart J       Date:  1988-11       Impact factor: 29.983

5.  The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.

Authors:  T Oga; K Nishimura; M Tsukino; T Hajiro; A Ikeda; T Izumi
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

6.  Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group.

Authors:  G F Fletcher; G Balady; V F Froelicher; L H Hartley; W L Haskell; M L Pollock
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

7.  Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation.

Authors:  S J Singh; M D Morgan; A E Hardman; C Rowe; P A Bardsley
Journal:  Eur Respir J       Date:  1994-11       Impact factor: 16.671

8.  Comparison of pulmonary gas exchange measurements between incremental and constant work exercise above the anaerobic threshold.

Authors:  R J Zeballos; I M Weisman; S M Connery
Journal:  Chest       Date:  1998-03       Impact factor: 9.410

Review 9.  Asthma and exercise.

Authors:  D Cypcar; R F Lemanske
Journal:  Clin Chest Med       Date:  1994-06       Impact factor: 2.878

10.  Development of a shuttle walking test of disability in patients with chronic airways obstruction.

Authors:  S J Singh; M D Morgan; S Scott; D Walters; A E Hardman
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.